Islet regeneration needed for overcoming autoimmune destruction - Considerations on the pathogenesis of type 1 diabetes

Pediatric Diabetes, Supplement

Volumn 5, Issue 2, 2004, Pages 23-28

  von Herrath, Matthias ^a   Homann, Dirk ^b  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Animal models; Autoimmune destruction; Cytotoxic T lymphocyte; Type 1 diabetes; cell regeneration

Indexed keywords

CD8 ANTIGEN;

ACCURACY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL COMPARTMENTALIZATION; CELL DEATH; CELL DESTRUCTION; CELL INTERACTION; CELL REGENERATION; CELL SYNCHRONIZATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CHRONIC DISEASE; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; EFFECTOR CELL; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; IMMUNOPATHOGENESIS; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; T LYMPHOCYTE;

EID: 11444250822     PISSN: 17451426     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-543x.2004.00076.x     Document Type: Article

References (21)

1. Steele C, Hagopian WA, Gitelman S et al. Insulin secretion in type 1 diabetes. Diabetes 2004: 53: 426-433.
2. Palmer JP, Fleming GA, Greenbaum CJ et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes 2004: 53: 250-264.
3. Torella R, Salvatore T, Cozzolino D, Grandillo F, Giugliano D. Pathophysiological study of the non-insulin-dependent phase of type I diabetes mellitus. Acta Diabetol Lat 1988: 25: 161-172.
4. Herold KC, Hagopian W, Auger JA et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 2002: 346: 1692-1698.
5. Raz I, Elias D, Avron A, Tamir M, Metzger M, Cohen IR. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet 2001: 358: 1749-1753.
6. Murtaugh LC, Melton DA. Genes, signals, and lineages in pancreas development. Annu Rev Cell Dev Biol 2003: 19: 71-89.
7. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004: 429: 41-46.
8. Kurts C, Carbone FR, Barnden M et al. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med 1997: 186: 2057-2062.
9. Waters JB, Oldstone MB, Hahn KM. Changes in the cytoplasmic structure of CTLs during target cell recognition and killing. J Immunol 1996: 157: 3396-3403.
10. Stinchcombe JC, Bossi G, Booth S, Griffiths GM. The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 2001: 15: 751-761.
11. Byers AM, Kemball CC, Moser JM, Lukacher AE. Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells. J Immunol 2003: 171: 17-21.
12. Barber DL, Wherry EJ, Ahmed R. Cutting edge: rapid in vivo killing by memory CD8 T cells. J Immunol 2003: 171: 27-31.
13. Seewaldt S, Thomas HE, Ejrnaes M et al. Virus-induced autoimmune diabetes: most beta-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes. Diabetes 2000: 49: 1801-1809.
14. Thomas HE, Kay TW. Beta cell destruction in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Diabetes Metab Res Rev 2000: 16: 251-261.
15. Von Herrath MG, Dockter J, Oldstone MB. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1994: 1: 231-242.
16. Holz A, Brett K, Oldstone MB. Constitutive beta cell expression of IL-12 does not perturb self-tolerance but intensifies established autoimmune diabetes. J Clin Invest 2001: 108: 1749-1758.
17. Von Herrath MG, Wolfe T, Mohrle U, Coon B, Hughes A. Protection from type 1 diabetes in the face of high levels of activated autoaggressive lymphocytes in a viral transgenic mouse model crossed to the SV129 strain. Diabetes 2001: 50: 2700-2708.
18. Kodama S, Kuhtreiber W, Fujimura S, Dale EA, Faustman DL. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 2003: 302: 1223-1227.
19. Street CN, Lakey JR, Seeberger K et al. Heterogenous expression of nestin in human pancreatic tissue precludes its use as an islet precursor marker. J Endocrinol 2004: 180: 213-225.
20. De Haro-Hernandez R, Cabrera-Munoz L, Mendez JD. Regeneration of beta-cells and neogenesis from small ducts or acinar cells promote recovery of endocrine pancreatic function in alloxan-treated rats. Arch Med Res 2004: 35: 114-120.
21. Ritzel RA, Hansen JB, Veldhuis JD, Butler PC. Induction of beta-cell rest by a Kir6.2/SUR1-selective K(ATP)-channel opener preserves beta-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose. J Clin Endocrinol Metab 2004: 89: 795-805.